By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
Development strategies for insoluble compounds require not only measurement of solubility enhancements achieved through formulation but also assessment of the effect a formulation has on permeability. An new dissolution-permeability measurement platform (µFLUX™) allows simultaneous monitoring of both effects thereby providing an in vitro path to early in vivo predictive biorelevant absorption testing.
